Evidence map›Paper›PMID 41838876›Full record

ArticleBriefings in bioinformatics2026

A progressive fine-tuning framework with dynamic parameter selection for low-resource peptide-GPCR interaction prediction.

Mingqing Liu, Jinhui Xu, Ji Liu

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mingqing LiuSchool of Information Science and Technology, University of Science and Technology of China, No. 100 Fuxing Road, High-Tech District, Hefei, 230026 Anhui, China.ORCID 0009-0007-7314-6472
Jinhui XuSchool of Information Science and Technology, University of Science and Technology of China, No. 100 Fuxing Road, High-Tech District, Hefei, 230026 Anhui, China.
Ji LiuFaculty of Life and Health Sciences, Shenzhen University of Advanced Technology, No. 1 Gongchang Road, Guangming District, Shenzhen, 518107 Guangdong, China.

Funding

National Natural Science Foundation of China 32571204 to J.L.National Natural Science Foundation of China 82495183
6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) are among the most important drug targets, and peptide therapeutics are rapidly emerging. However, accurate prediction of peptide-GPCR interactions (PepGI) remains challenging due to the scarcity of high-quality data and the poor generalization of existing drug-target interaction (DTI) models, which are largely trained on small molecule data. Here, we introduce a progressive fine-tuning framework with a dynamic parameter selection strategy that adaptively selects critical fine-tuning parameters using Fisher information. Our method begins with pretraining on a large small molecule-GPCR dataset, followed by intermediate fine-tuning on peptide-target data to alleviate the representation mismatch across heterogeneous ligand modalities. Finally, the task-specific fine-tuning is performed on the low-resource PepGI scenario. Extensive experiments show that our approach significantly outperforms baselines across multiple evaluation metrics, and exhibits robust generalization under few-shot and practical cold-start settings. Overall, this work offers an effective solution for low-resource peptide-GPCR prediction and presents a transferable framework for cross-structure DTI modeling.

Indexed as

Computational BiologyPeptidesReceptors, G-Protein-CoupledAlgorithmsHumansLigandsPrediction AlgorithmsProtein BindingLigandsPeptidesReceptors, G-Protein-Coupleddrug–target interaction predictiondynamic parameter selectionfew-shot learningpeptide–GPCR interactionprogressive fine-tuning

Identifiers

PMID41838876
PMCPMC12991051

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.